Biocon Shares Gain 1% on VAI Status from USFDA
Shares of Biocon Ltd were trading in the green and 1% higher on 27 November after the company announced that the US Food and Drug...
Tag : voluntary action indicated (VAI)
Natco Pharma Shares Surge 3% as Hyderabad Unit Gets EIR
Shares of Natco Pharma Ltd surged 3% on Thursday, 18 September, after the company announced that its unit in Hyderabad received EIR from the USFDA. ...
Aurobindo Pharma Shares Slump 2% Despite Telangana Secures VAI Status
Shares of Aurobindo Pharma Ltd slumped 2% on 28 January despite the company declaring that the Telangana active pharmaceutical ingredient (API) factory owned by one...
Biocon Shares Gain 4% as Malaysia Unit Gets Clearance from USFDA
Shares of Biocon were trading 4% higher on 13 January after the company’s subsidiary Biocon Biologics’ insulin factory in Malaysia got cleared by the US...
Biocon Shares Slump 4% as Bengaluru API Unit Gets VAI Tag
Shares of Biocon Ltd slumped 4% on Monday, 9 December, after the company’s Bengaluru Unit received an Establishment Inspection Report (EIR) with a Voluntary Action...
Zydus Life Shares Soar High on Receiving USFDA Approval for Ahmedabad Facility
Shares of Zydus Lifesciences were trading higher by 1% on 1 October after the company announced that it had received an ‘Establishment Inspection Report (EIR)’...
Dr Reddy’s Laboratories Receives VAI Classification from USFDA; Shares Trade Lower
Shares of Dr Reddy’s Laboratories Ltd (DRL) were trading in the red after the company announced that it had obtained an Establishment Inspection Report (EIR)...
Torrent Pharma Shares Soar 4% as USFDA Issues EIR for Indrad
Shares of Torrent Pharmaceuticals Ltd surged 4% on Friday 30 August, reaching a fresh high of Rs 3,574 on the NSE. This was following the...
Jubilant Pharmova Shares Slump 4% as Canada Facility Receives VAI Status from USFDA
Shares of Jubilant Pharmova slumped 4% on 22 July after the company’s Canada plant as having a “voluntary action indicated” (VAI) status by the US...
Aurobindo Pharma Subsidiary’s Telangana Units Gets VAI Status from USFDA
Aurobindo Pharma subsidiary Eugia Pharma’s injectable plant in Telangana was classified by the US Food and Drug Administration (USFDA) in an establishment inspection report as...